![]() 966,290,796 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
ASCVD |
0.06 sec. |
|
|
? References in periodicals archive |
|---|
The technology is incorporated in the Company's AtherOx[TM] product group, a next-generation technology to identify individuals at risk for developing atherosclerotic cardiovascular disease. DENVER -- Corgenix Medical Corporation (OTC BB: CONX) has submitted a 510(K) Premarket Notification submission to the Unites States Food and Drug Administration (FDA) for AtherOx(TM), its next-generation product group utilizing a patented technology to identify individuals at risk for developing atherosclerotic cardiovascular disease. Applications of Time-Resolved Fluorescence Spectroscopy to Atherosclerotic Cardiovascular Disease and Brain Tumors Diagnosis. |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content NEW! | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|